Press releases

25 July 2012

MHH and Rentschler Sign Licensing Agreement for an Innovative Gene Therapy Vector System

The Hannover Medical School (MHH) and Rentschler Biotechnologie GmbH have signed a licensing agreement for the commercialization of a vector system for gene therapy that promises significant therapeutic and economic advantages... [more]

15 June 2012

REBIRTH successful in the second phase of the Excellence Initiative

Success for Hannover Medical School (MHH): within the Excellence Initiative jointly funded by Germany’s federal and state governments, MHH is to receive funding for its two Clusters of Excellence entitled ‘From Regenerative... [more]

07 June 2012

New to the REBIRTH team

Dr. Sotiris Korossis has recently started working as Director of Biomedical Engineering at the Department of Cardiac, Thoracic, Transplantation and Vascular Surgery (HTTG) at Hannover Medical School (MHH). Dr Korossis completed... [more]

12 May 2012

Ten years of innovative heart valves from Hannover

Bright eyes and happy smiles on the faces of children, young people and adults alike are nothing unusual at Hannover Adventure Zoo. On Saturday, however, it was a very special group that met at the zoo to have fun together:... [more]

21 March 2012

Abitur and then what? The Voluntary Scientific Year

This year the Hannover Medical School (MHH) offers the Voluntary Scientific Year (FWJ) again. The FWJ is a pilot scheme under the auspices of Germany’s ‘Freiwilliges Soziales Jahr‘ or FSJ – enabling upper secondary-school leavers... [more]

09 March 2012

„Medical history being made in Hannover“

The medicine of tomorrow is already reality today: on a visit to Hannover Medical School (MHH), Federal Minister Dr Ursula von der Leyen, the patron of the association promoting children’s heart centres in Germany... [more]

22 February 2012

REBIRTH researchers untangel blood vessel branching

New perspectives for vessel regeneration: Blood vessels form intricate, three-dimensional branched structures that supply each organ with oxygen and nutrients. However, once adult blood vessels are established they do not easily... [more]

16 January 2012

Zender receives Johann Georg Zimmermann Award

One of the most prestigious awards for contributions to cancer research in Germany is to be presented by Deutsche Hypothekenbank AG at Hannover Medical School (MHH) on Monday, 16 January 2012. The Johann Georg Zimmermann Research... [more]

02 January 2012

Transplantation: study on heart valves that last a lifetime

Transplanting a heart valve that is not rejected, lasts a lifetime and, in children, even grows with the body – this is the aim of the ‘European clinical study for the application of regenerative heart valves’ (ESPOIR). Headed by... [more]

25 December 2011

The first high-tech auction in Germany: 25 investors buy a stake in REBIRTH Spin-off

The Hannover-based nanotechnology company called Particular, a spin-off from REBIRTH’s Nanoparticles work group, is the first German high-tech start-up to successfully hold a crowdfunding auction: it raised 100,000 euros’ worth... [more]

22 November 2011

TV report: Will artificial and pig heart valves soon be a thing of the past?

Professor Haverich gives TV interview for the medical magazine programme ‘Visite’ On 22 November 2011 at 8.15 p.m. in its feature item entitled ‘New heart valves: which method for which patient?’ the NDR network’s health show... [more]

21 November 2011

Klusmann leads Emmy Noether junior research group

To better understand the origins of leukaemia and thus develop therapies for this disease, the work group led by Dr Jan-Henning Klusmann is investigating the role played by ribonucleic acids in blood formation. Dr Klusmann, a... [more]

11 November 2011

REBIRTH spin-off sells shares in nanotechnology profits

The Hannover-based company called Particular GmbH, a spin-off from REBIRTH’s Nanoparticles research group which produces nanoparticles for biological and medical uses, sees itself not only as a technological trailblazer for... [more]

09 November 2011

The body’s own defences track down ‘hibernating’ cancer cells

Liver cell carcinoma is one of the most frequent malignant types of cancer worldwide. It is usually triggered by cirrhosis of the liver, which is in turn caused by chronic infection with the Hepatitis B or C virus. Researchers at... [more]

02 November 2011

Heineke receives the Sir Hans Krebs Prize

On 2 November, during the Annual General Meeting of the Society of Friends of Hannover Medical School (GdF), PD Dr Jörg Heineke was awarded the Sir Hans Krebs Prize for 2011, which is worth 10,000 euros and is endowed by... [more]

test
This website uses cookies and the web analytics service Google Analytics. Click here for further information on privacy.
I agree